NEOS Neos Therapeutics, Inc.

8.30
+0.35  (4%)
Previous Close 7.95
Open 7.95
Price To book 14.22
Market Cap 187.25M
Shares 22,560,000
Volume 421,610
Short Ratio 7.17
Av. Daily Volume 293,717

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

NDA submission announced November 15, 2016. PDUFA estimate November 15, 2017.
NT-0201
Attention deficit hyperactivity disorder (ADHD)
Approved January 27, 2016.
Adzenys XR-ODT
Attention deficit hyperactivity disorder (ADHD)
CRL issued November 2015. PDUFA date June 19, 2017.
Cotempla XR-ODT
Attention deficit hyperactivity disorder (ADHD)